Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.6616
+0.0016 (0.24%)
At close: Feb 24, 2026, 4:00 PM EST
0.6400
-0.0216 (-3.26%)
Pre-market: Feb 25, 2026, 4:24 AM EST
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $32.11 million as of February 25, 2026. Its market cap has decreased by -47.01% in one year.
Market Cap
32.11M
Enterprise Value
3.70M
1-Year Change
-47.01%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $32.11M, a decrease of -92.71%. That is a compound annual growth rate of -41.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 32.11M | 4.44% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | 440.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| INmune Bio | 34.83M |
| Outlook Therapeutics | 34.32M |
| Tvardi Therapeutics | 34.15M |
| Kyntra Bio | 33.66M |
| RenovoRx | 33.45M |
| Actinium Pharmaceuticals | 33.07M |
| Tempest Therapeutics | 32.35M |
| Rein Therapeutics | 31.81M |